Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea
· Delayed Price · Currency is KRW 4,230.00
-15.00 (-0.35%)
At close: Apr 28, 2026
Korean Drug Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 46,321 | 46,922 | 50,141 | 78,348 | 85,441 | 97,444 | Upgrade
|
| Market Cap Growth | -5.77% | -6.42% | -36.00% | -8.30% | -12.32% | -13.30% | Upgrade
|
| Enterprise Value | 16,383 | 17,968 | 30,087 | 41,605 | 53,950 | 71,749 | Upgrade
|
| Last Close Price | 4245.00 | 4300.00 | 4405.30 | 6649.24 | 7098.22 | 7914.17 | Upgrade
|
| PE Ratio | 7.11 | 7.21 | 16.74 | - | 7.24 | 10.78 | Upgrade
|
| PS Ratio | 0.74 | 0.75 | 0.69 | 0.96 | 1.07 | 1.31 | Upgrade
|
| PB Ratio | 0.56 | 0.56 | 0.64 | 1.02 | 1.01 | 1.27 | Upgrade
|
| P/TBV Ratio | 0.56 | 0.57 | 0.64 | 1.02 | 1.01 | 1.27 | Upgrade
|
| P/FCF Ratio | 3.66 | 3.71 | 13.05 | - | - | 12.72 | Upgrade
|
| P/OCF Ratio | 3.53 | 3.58 | 10.30 | - | 14.45 | 11.07 | Upgrade
|
| EV/Sales Ratio | 0.26 | 0.29 | 0.41 | 0.51 | 0.68 | 0.96 | Upgrade
|
| EV/EBITDA Ratio | 1.84 | 2.02 | 4.87 | 4.91 | 3.43 | 5.63 | Upgrade
|
| EV/EBIT Ratio | 2.37 | 2.60 | 7.33 | 6.19 | 3.77 | 6.37 | Upgrade
|
| EV/FCF Ratio | 1.29 | 1.42 | 7.83 | - | - | 9.37 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.02 | - | - | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.36 | -0.24 | -0.22 | -0.31 | -0.36 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.37 | -3.37 | -3.06 | -1.97 | -1.68 | -2.18 | Upgrade
|
| Net Debt / FCF Ratio | -2.37 | -2.37 | -4.92 | 2.14 | 146.19 | -3.63 | Upgrade
|
| Asset Turnover | 0.68 | 0.68 | 0.82 | 0.88 | 0.87 | 0.87 | Upgrade
|
| Inventory Turnover | 2.01 | 2.01 | 2.01 | 2.74 | 3.41 | 3.67 | Upgrade
|
| Quick Ratio | 6.41 | 6.41 | 5.81 | 4.52 | 7.81 | 5.51 | Upgrade
|
| Current Ratio | 8.33 | 8.33 | 8.73 | 6.41 | 9.80 | 6.82 | Upgrade
|
| Return on Equity (ROE) | 8.08% | 8.08% | 3.86% | -6.08% | 14.63% | 12.26% | Upgrade
|
| Return on Assets (ROA) | 4.72% | 4.72% | 2.87% | 4.56% | 9.78% | 8.19% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.97% | 10.28% | 4.12% | -6.73% | 21.49% | 18.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.00% | 8.00% | 5.00% | 8.40% | 16.50% | 14.40% | Upgrade
|
| Earnings Yield | 14.06% | 13.88% | 5.97% | -6.28% | 13.82% | 9.28% | Upgrade
|
| FCF Yield | 27.32% | 26.97% | 7.66% | -9.97% | -0.21% | 7.86% | Upgrade
|
| Payout Ratio | 26.57% | 26.57% | 54.02% | - | 15.52% | 18.07% | Upgrade
|
| Buyback Yield / Dilution | - | - | -0.08% | 0.01% | 1.30% | -0.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.